APA

Geusens P., Oates M., Miyauchi A., Adachi J. D., Lazaretti-Castro M., Ebeling P. R., Perez Niño C. A., Milmont C. E., Grauer A. & Libanati C. (2019). The Effect of 1 Year of Romosozumab on the Incidence of Clinical Vertebral Fractures in Postmenopausal Women With Osteoporosis: Results From the FRAME Study. : JBMR plus.

Chicago

Geusens Piet, Oates Mary, Miyauchi Akimitsu, Adachi Jonathan D, Lazaretti-Castro Marise, Ebeling Peter R, Perez Niño Carlos Augusto, Milmont Cassandra E, Grauer Andreas and Libanati Cesar. 2019. The Effect of 1 Year of Romosozumab on the Incidence of Clinical Vertebral Fractures in Postmenopausal Women With Osteoporosis: Results From the FRAME Study. : JBMR plus.

Harvard

Geusens P., Oates M., Miyauchi A., Adachi J. D., Lazaretti-Castro M., Ebeling P. R., Perez Niño C. A., Milmont C. E., Grauer A. and Libanati C. (2019). The Effect of 1 Year of Romosozumab on the Incidence of Clinical Vertebral Fractures in Postmenopausal Women With Osteoporosis: Results From the FRAME Study. : JBMR plus.

MLA

Geusens Piet, Oates Mary, Miyauchi Akimitsu, Adachi Jonathan D, Lazaretti-Castro Marise, Ebeling Peter R, Perez Niño Carlos Augusto, Milmont Cassandra E, Grauer Andreas and Libanati Cesar. The Effect of 1 Year of Romosozumab on the Incidence of Clinical Vertebral Fractures in Postmenopausal Women With Osteoporosis: Results From the FRAME Study. : JBMR plus. 2019.